Medicare Part D coverage · chlorthalidone · RxCUI 214081

chlorthalidone 15 MG Oral Tablet [Thalitone]

Per the CMS 2026 Part D formulary file, chlorthalidone 15 MG Oral Tablet [Thalitone] is covered by 4 Medicare Part D plans (0.1% of enrollable products), averaging Tier 4, with prior authorization required on 0% of covering formularies.

0.1%
Plan coverage
4
Plans covering
T4
Avg tier
0%
Prior auth required

Verify with CMS →

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.

What the CMS Formulary Data Shows for chlorthalidone 15 MG Oral Tablet [Thalitone]

Per the CMS 2026 Part D formulary file, chlorthalidone 15 MG Oral Tablet [Thalitone] (RxNorm concept RXCUI 214081, generic name chlorthalidone) appears on 1 distinct formulary file spanning 4 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 4 to Tier 4, with a cross-plan average of Tier 4.

Real-world access to chlorthalidone 15 MG Oral Tablet [Thalitone] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 783,324 Part D beneficiaries filled chlorthalidone 15 MG Oral Tablet [Thalitone] in 2023, with total plan-and-beneficiary spending of $64,664,899 and an average per-beneficiary annual cost of $82.55. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry chlorthalidone 15 MG Oral Tablet [Thalitone] today.

Coverage Details

Formularies covering
1
Plans covering
4
Coverage rate
0.1%
Tier range
Tier 4, Non-Preferred
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
0% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
783,324
Total spending
$64,664,899
Avg per beneficiary
$82.55

Tier Distribution Across Plans

4 plans
Tier 4, Non-Preferred

Medicare Advantage Plans (MA-PD) Covering chlorthalidone 15 MG Oral Tablet [Thalitone]

4 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Health New England Medicare Compass (PPO) Health NEW England, Inc. T4 No $0 MA
Health New England Medicare Value (HMO) Health NEW England, Inc. T4 No $0 MA
Health New England Medicare Premium (HMO) Health NEW England, Inc. T4 No $15.80 MA
Health New England Medicare Plus (HMO) Health NEW England, Inc. T4 No $58.40 MA

Frequently Asked Questions

Is chlorthalidone 15 MG Oral Tablet [Thalitone] covered by Medicare Part D?

Yes, chlorthalidone 15 MG Oral Tablet [Thalitone] is covered by 4 Medicare Part D plans (0.1% of all Part D formularies).

What tier is chlorthalidone 15 MG Oral Tablet [Thalitone] on Medicare Part D plans?

chlorthalidone 15 MG Oral Tablet [Thalitone] averages Tier 4 across Part D plans, ranging from Tier 4 to Tier 4.

Does chlorthalidone 15 MG Oral Tablet [Thalitone] require prior authorization?

0% of Part D formularies require prior authorization for chlorthalidone 15 MG Oral Tablet [Thalitone]. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on chlorthalidone 15 MG Oral Tablet [Thalitone]?

In 2023, total Medicare Part D spending on chlorthalidone 15 MG Oral Tablet [Thalitone] was $64,664,899, covering 783,324 beneficiaries. The average spend per beneficiary was $82.55.

Nationwide similar Part D drugs

Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare